Table 3. Meta-analysis of Apolipoprotein E gene polymorphism in Alzheimer's disease.
| Fix-effect model | Random-effect model | |||||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P | Ph | I2 | OR (95% CI) | P | Ph | I2 | |
| Allele | ||||||||
| ApoE ε2 | 0.88 (0.73, 1.07) | 0.20 | 0.0002 | 61% | 0.93 (0.66, 1.29) | 0.65 | 0.0002 | 61% |
| ApoE ε3 | 0.42 (0.37, 0.47) | <0.00001 | 0.07 | 34% | 0.42 (0.36, 0.49) | <0.00001 | 0.07 | 34% |
| ApoE ε4 | 3.93 (3.37, 4.58) | <0.00001 | 0.81 | 0% | 3.89 (3.33, 4.54) | <0.00001 | 0.81 | 0% |
| Genotype | ||||||||
| ApoE ε4/ε4 | 11.71 (6.38, 21.47) | <0.00001 | 0.98 | 0% | 9.84 (5.28, 18.34) | <0.00001 | 0.98 | 0% |
| ApoE ε3/ε3 | 0.39 (0.33, 0.45) | <0.00001 | 0.25 | 16% | 0.38 (0.33, 0.45) | <0.00001 | 0.25 | 16% |
| ApoE ε2/ε2 | 1.06 (0.55, 2.06) | 0.86 | 0.60 | 0% | 1.09 (0.52, 2.27) | 0.83 | 0.60 | 0% |
| ApoE ε4/ε3 | 3.08 (2.57, 3.69) | <0.00001 | 0.06 | 35% | 3.16 (2.48, 4.02) | <0.00001 | 0.06 | 35% |
| ApoE ε3/ε2 | 0.67 (0.53, 0.85) | 0.0008 | 0.18 | 23% | 0.66 (0.49, 0.88) | 0.005 | 0.18 | 23% |
| ApoE ε4/ε2 | 2.10 (1.35, 3.26) | 0.001 | 0.32 | 11% | 1.92 (1.13, 3.28) | 0.02 | 0.32 | 11% |
Ph, Pheterogeneity.